Clinical Trial Update: Caelyx Adjuvant in Elderly Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating Caelyx (pegylated liposomal doxorubicin) as adjuvant therapy in elderly patients with breast cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Breast Cancer, Elderly | Phase 2 | Status: COMPLETED